Advertisement
News
Subscribe to Bioscience Technology News

The Lead

Study Examines Cancer Risk from First Atom-bomb Test

September 30, 2014 | by Susan Montoya Bryan - Associated Press - Associated Press | Comments

Researchers from the National Cancer Institute want to know how many past and present cancer cases in New Mexico may be related to the U.S. government's test of the world's first atomic bomb over a remote stretch of desert nearly 70 years ago.  

TOPICS:
View Sample

FREE Email Newsletter Bioscience Technology Daily

Research Explores New Possibilities for Epilepsy Treatment

October 1, 2014 3:34 pm | Comments

Ongoing research is investigating the connection between initial seizures and the onset of epilepsy later in life. Nearly one in 10 Americans will experience an initial seizure, but only 3 percent of those who experience a seizure will go on to develop epilepsy.

TOPICS:

Gene Interacts With Stress, Leads to Heart Disease

October 1, 2014 3:33 pm | Comments

A new genetic finding suggests that some people who are prone to hostility, anxiety and depression might also be hard-wired to gain weight when exposed to chronic stress, leading to diabetes and heart disease.           

TOPICS:

Omega-3 Fatty Acids May Prevent Some Forms of Depression

October 1, 2014 3:29 pm | Comments

Omega-3 fatty acids, more commonly known as fish oil, have a long list of health benefits, including lowering the risk of heart disease and reducing triglyceride levels. These nutritional compounds are also known to have anti-depressant and anti-inflammatory properties.

TOPICS:
Advertisement

Merck completes sale of consumer unit to Bayer

October 1, 2014 12:37 pm | by The Associated Press | Comments

Drugmaker Merck said Wednesday that it completed the sale of its consumer care business, which makes products including Claritin allergy medication and Coppertone sun-care line, to German health care company Bayer for $14.2 billion. Bayer AG agreed to buy the business in May. Merck, of Whitehouse...

10 Questions, Answers About the U.S. Ebola Case

October 1, 2014 3:36 am | by Lauran Neergaard - AP Medical Writer - Associated Press | Comments

U.S. health officials have warned for months that someone infected with Ebola could unknowingly carry the virus to this country, and there is word now that it has happened: A traveler in a Dallas hospital became the first patient diagnosed in the U.S.

TOPICS:

Ebola case stokes concerns for Liberians in Texas

October 1, 2014 2:36 am | by David Warren - Associated Press - Associated Press | Comments

The first case of Ebola diagnosed in the U.S. has been confirmed in a man who recently traveled from Liberia to Dallas, sending chills through the area's West African community whose leaders urged caution to prevent spreading the virus. The unidentified man was critically ill and has been in...

FTC to retailers: Drop your caffeinated drawers

September 30, 2014 7:36 pm | by Jonathan J. Cooper - Associated Press - Associated Press | Comments

If you purchased caffeine-infused underwear because of promises it will make you thinner, federal regulators say you were hoodwinked — but at least you can get your money back. The Federal Trade Commission announced Monday that two companies — Norm Thompson Outfitters of Oregon and Wacoal America...

Timeline for first case of Ebola diagnosed in US

September 30, 2014 7:36 pm | by The Associated Press | Comments

The first person to be diagnosed with Ebola in the United States flew from Liberia, federal health officials said. The unidentified man, who traveled to Dallas to visit family, is being treated at Texas Health Presbyterian Hospital: Sept. 19 — Departs from Liberia Sept. 20 — Arrives in the...

Advertisement

The US Ebola case: 5 things to know

September 30, 2014 7:36 pm | by Marilynn Marchione - AP Chief Medical Writer - Associated Press | Comments

Health officials on Tuesday announced the first case of Ebola diagnosed in the United States — a man isolated in intensive care at Texas Health Presbyterian Hospital in Dallas. Five things to know about the case: WHEN AND HOW IT HAPPENED Health officials say they don't know how the man was...

Comprehensive Study of Allergic Deaths in U.S. Finds Medications are Main Culprit

September 30, 2014 5:37 pm | by Einstein | Comments

September 30, 2014—(BRONX, NY)—Medications are the leading cause of allergy-related sudden deaths in the U.S., according to an analysis of death certificates from 1999 to 2010, conducted by researchers at Montefiore Medical Center and Albert Einstein College of Medicine of Yeshiva...

Early Antibiotic Use Linked to Childhood Obesity Risk

September 30, 2014 2:22 pm | Comments

The use of broad-spectrum antibiotics by children before the age of 24 months was associated with increased risk of obesity in early childhood, according to a new study.                       

TOPICS:

Scientists Discover Gene Controlling Muscle Fate

September 30, 2014 2:11 pm | Comments

Scientists have moved a step closer to improving medical science through research involving muscle manipulation of fruit flies. They discovered in the flight muscles of Drosophila a new regulator of a process called alternative splicing.     

TOPICS:

Drug and Device Firms Paid $3.5B to Care Providers

September 30, 2014 2:02 pm | by Ricardo Alonso-Zaldivar - Associated Press - Associated Press | Comments

Striving to shine a light on potential ethical conflicts in medicine, the Obama administration is releasing data on drug company payments to tens of thousands of individual doctors.                    

TOPICS:

Modeling Shockwaves Through the Brain

September 30, 2014 2:00 pm | Comments

Researchers have developed a scaling law that predicts a human’s risk of brain injury, based on previous studies of blasts’ effects on animal brains. The method may help the military develop more protective helmets, as well as aid clinicians in diagnosing traumatic brain injury.

TOPICS:

NIH Awards Initial $46M for BRAIN Initiative Research

September 30, 2014 1:51 pm | Comments

The National Institutes of Health announced today its first wave of investments totaling $46 million in fiscal year 14 funds to support the goals of the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative.     

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading